Abstract 4317: Developing near infrared (NIR) optical retinoid analogue for cancer imaging

Imaging technology plays an important role in early detection of cancers and improved prognoses. Among of the various imaging techniques used near infrared (NIR) optical imaging is an active and promising area for both in vitro and in vivo molecular imaging studies. However, NIR fluorophores normally only possess optical imaging properties without selectivity to diseased tissues. To address this problem, a targeting moiety can be introduced to help to deliver the imaging report to its target. It is know that retinoids, analogs of vitamin A, are assessed for multiple therapeutic uses. In practically, their potential chemopreventive and therapeutic roles in different kinds of cancers have attracted much attention. The cancer types include head and neck, lung, breast, esophagus, colon, kidney, prostate, bladder cancers and so on. Considering about important role of retinoids in cancer treatment developing retinoid derivatives as targeting imaging agents should be a useful strategy for noninvasive detection and characterization of solid tumors. Herein, we developed fluorescent retinoid derivatives for cancer imaging. Several different cancer cell lines and cancer xenograft models were used in this study. The data demonstrate that this new imaging agent can be used to imaging different kinds of cancers from cell level to whole body. Furthermore, these imaging agents have the potential to develop into special therapeutic agents that can be used for diagnosis, treatment and monitor of retinoid positive diseases. Note: This abstract was not presented at the AACR 101st Annual Meeting 2010 because the presenter was unable to attend. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 4317.